Context Therapeutics
Price & Volume
Stats
See more52W Range | $0.79-$2.75 |
Market Cap | $68.4M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.88 |
News
See moreYahoo Finance • last year
Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
Yahoo Finance • last year
Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Yahoo Finance • 2 years ago
Context Therapeutics Reports First Quarter 2023 Operating and Financial Results
About
CEO | Mr. Martin A. Lehr |
CFO | Ms. Jennifer Minai-Azary |
Address | 2001 Market Street, Philadelphia, PA, United States, 19103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |
